Cashu
Class Action Against uniQure N.V. Over Alleged Drug Approval Misrepresentation
3 days ago
Stocks
Health Care
qure
uniQure N.V.
NASDAQ: QURE
+0.55 (+3.73%)
15.28
USD
At close at Mar 19, 20:40 UTC
Latest uniQure N.V. News
prnewswire.com
uniQure N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QURE
13 minutes ago
prnewswire.com
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 13, 2026 in uniQure Lawsuit - QURE
2 days ago
prnewswire.com
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit
4 days ago
prnewswire.com
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
6 days ago
prnewswire.com
uniQure N.V. (QURE) Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP: Investors Face April 13, 2026, Deadline
7 days ago
prnewswire.com
uniQure N.V. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 13, 2026 to Discuss Your Rights - QURE
10 days ago
benzinga.com
uniQure Shares Surge 26% On US FDA Shakeup Even As Momentum Tumbles: Will New Leadership Greenlight Huntington's Therapy?
10 days ago
benzinga.com
What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?
11 days ago
benzinga.com
What the Options Market Tells Us About uniQure
11 days ago
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
11 days ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.